Fintel reports that on February 13, 2025, Piper Sandler initiated coverage of Merus N.V. (NasdaqGM:MRUS) with a Overweight ...
Piper Sandler analyst Matt O’Brien raised the firm’s price target on AtriCure (ATRC) to $50 from $40 and keeps an Overweight rating on the ...
Q32 Bio (NASDAQ:QTTB – Get Free Report) was downgraded by equities researchers at Piper Sandler from an “overweight” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat ...
Piper Sandler downgraded Olin Corporation (NYSE:OLN) to "Neutral" from "Overweight" and lowered its price target to $33 from ...
Microsoft Corporation's cloud computing platform, Azure's workloads could push its artificial intelligence revenue to $10 billion.
Piper Sandler reiterated their overweight rating on shares of CNO Financial Group (NYSE:CNO – Free Report) in a research ...
Upstart Holdings, Inc. (NASDAQ:UPST) shares are trading higher on Wednesday. The company reported fourth-quarter results yesterday, with total revenue up 56% year-over-year. Total fee revenue ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
MINNEAPOLIS, February 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of ...
Piper Sandler analyst David Amsellem maintained a Hold rating on Biogen (BIIB – Research Report) today and set a price target of $138.00. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback